| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.861 | 0.004 | 0.861 | HERG channel blocker | 0.777 0.005 DBMET00839 0.777 0.005 DBMET00914 0.777 0.005 DBMET01547 | ||
| 0.837 | 0.002 | 0.837 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.68 0.003 DBMET00839 0.68 0.003 DBMET00914 0.68 0.003 DBMET01547 | ||
| 0.83 | 0.004 | 0.83 | Potassium channel (Voltage-sensitive) blocker | 0.748 0.005 DBMET00839 0.748 0.005 DBMET00914 0.748 0.005 DBMET01547 | ||
| 0.806 | 0.003 | 0.806 | Vasodilator | 0.767 0.003 DBMET00839 0.767 0.003 DBMET00914 0.767 0.003 DBMET01547 | ||
| 0.798 | 0.004 | 0.798 | Cardiotonic | 0.757 0.005 DBMET00839 0.757 0.005 DBMET00914 0.757 0.005 DBMET01547 | ||
| 0.717 | 0.002 | 0.717 | Sigma receptor agonist | 0.673 0.003 DBMET00839 0.673 0.003 DBMET00914 0.673 0.003 DBMET01547 | ||
| 0.71 | 0.002 | 0.71 | Melatonin antagonist | 0.31 0.003 DBMET00839 0.31 0.003 DBMET00914 0.31 0.003 DBMET01547 | ||
| 0.711 | 0.004 | 0.711 | Potassium channel blocker | 0.585 0.006 DBMET00839 0.585 0.006 DBMET00914 0.585 0.006 DBMET01547 | ||
| 0.666 | 0.008 | 0.709 | Spasmolytic | 0.709 0.005 DBMET00839 0.709 0.005 DBMET00914 0.709 0.005 DBMET01547 | DBMET01547 | |
| 0.655 | 0.002 | 0.655 | Melatonin 1 antagonist | 0.236 0.003 DBMET00839 0.236 0.003 DBMET00914 0.236 0.003 DBMET01547 | ||
| 0.624 | 0.004 | 0.624 | Cholinergic antagonist | 0.605 0.004 DBMET00839 0.605 0.004 DBMET00914 0.605 0.004 DBMET01547 | ||
| 0.623 | 0.004 | 0.623 | Acetylcholine antagonist | 0.603 0.004 DBMET00839 0.603 0.004 DBMET00914 0.603 0.004 DBMET01547 | ||
| 0.583 | 0.003 | 0.583 | Adrenaline uptake inhibitor | 0.41 0.004 DBMET00839 0.41 0.004 DBMET00914 0.41 0.004 DBMET01547 | ||
| 0.571 | 0.009 | 0.628 | Vasodilator, coronary | 0.628 0.006 DBMET00839 0.628 0.006 DBMET00914 0.628 0.006 DBMET01547 | DBMET01547 | |
| 0.521 | 0.004 | 0.521 | Acetylcholine M1 receptor antagonist | 0.499 0.004 DBMET00839 0.499 0.004 DBMET00914 0.499 0.004 DBMET01547 | ||
| 0.516 | 0.025 | 0.516 | 5 Hydroxytryptamine release stimulant | 0.453 0.036 DBMET00839 0.453 0.036 DBMET00914 0.453 0.036 DBMET01547 | ||
| 0.48 | 0.003 | 0.48 | Acetylcholine M4 receptor antagonist | 0.262 0.004 DBMET00839 0.262 0.004 DBMET00914 0.262 0.004 DBMET01547 | ||
| 0.462 | 0.004 | 0.462 | Acetylcholine muscarinic antagonist | 0.452 0.004 DBMET00839 0.452 0.004 DBMET00914 0.452 0.004 DBMET01547 | ||
| 0.423 | 0.005 | 0.423 | GABA C receptor agonist | 0.29 0.01 DBMET00839 0.29 0.01 DBMET00914 0.29 0.01 DBMET01547 | ||
| 0.409 | 0.012 | 0.409 | Diuretic | 0.396 0.013 DBMET00839 0.396 0.013 DBMET00914 0.396 0.013 DBMET01547 | ||
| 0.359 | 0.014 | 0.359 | Tyrosine 3 hydroxylase inhibitor | 0.28 0.044 DBMET00839 0.28 0.044 DBMET00914 0.28 0.044 DBMET01547 | ||
| 0.348 | 0.005 | 0.348 | Acetylcholine nicotinic antagonist | 0.273 0.008 DBMET00839 0.273 0.008 DBMET00914 0.273 0.008 DBMET01547 | ||
| 0.344 | 0.003 | 0.344 | Somatostatin 2 agonist | 0.107 0.004 DBMET00839 0.107 0.004 DBMET00914 0.107 0.004 DBMET01547 | ||
| 0.41 | 0.074 | 0.41 | Calcium channel L-type activator | 0.358 0.111 DBMET00839 0.358 0.111 DBMET00914 0.358 0.111 DBMET01547 | ||
| 0.338 | 0.007 | 0.338 | Calcium channel blocker | 0.206 0.027 DBMET00839 0.206 0.027 DBMET00914 0.206 0.027 DBMET01547 | ||
| 0.359 | 0.03 | 0.368 | Psychostimulant | 0.368 0.028 DBMET00839 0.368 0.028 DBMET00914 0.368 0.028 DBMET01547 | DBMET01547 | |
| 0.334 | 0.014 | 0.334 | 5 Hydroxytryptamine 1E antagonist | 0.251 0.074 DBMET00839 0.251 0.074 DBMET00914 0.251 0.074 DBMET01547 | ||
| 0.38 | 0.062 | 0.439 | Vasodilator, peripheral | 0.439 0.044 DBMET00839 0.439 0.044 DBMET00914 0.439 0.044 DBMET01547 | DBMET01547 | |
| 0.342 | 0.028 | 0.342 | 5 Hydroxytryptamine uptake stimulant | 0.278 0.058 DBMET00839 0.278 0.058 DBMET00914 0.278 0.058 DBMET01547 | ||
| 0.346 | 0.035 | 0.346 | Insulysin inhibitor | 0.272 0.078 DBMET00839 0.272 0.078 DBMET00914 0.272 0.078 DBMET01547 | ||
| 0.311 | 0.004 | 0.322 | Acetylcholine M3 receptor antagonist | 0.322 0.004 DBMET00839 0.322 0.004 DBMET00914 0.322 0.004 DBMET01547 | DBMET01547 | |
| 0.371 | 0.077 | 0.401 | Antiobesity | 0.401 0.065 DBMET00839 0.401 0.065 DBMET00914 0.401 0.065 DBMET01547 | DBMET01547 | |
| 0.286 | 0.004 | 0.286 | Acetylcholine M5 receptor antagonist | 0.207 0.005 DBMET00839 0.207 0.005 DBMET00914 0.207 0.005 DBMET01547 | ||
| 0.273 | 0.004 | 0.273 | Nicotinic alpha4beta2 receptor antagonist | 0.176 0.005 DBMET00839 0.176 0.005 DBMET00914 0.176 0.005 DBMET01547 | ||
| 0.266 | 0.005 | 0.266 | Somatostatin agonist | 0.077 0.009 DBMET00839 0.077 0.009 DBMET00914 0.077 0.009 DBMET01547 | ||
| 0.245 | 0.005 | 0.245 | Sphingomyelinase inhibitor | 0.213 0.007 DBMET00839 0.213 0.007 DBMET00914 0.213 0.007 DBMET01547 | ||
| 0.254 | 0.019 | 0.257 | Anesthetic local | 0.257 0.019 DBMET00839 0.257 0.019 DBMET00914 0.257 0.019 DBMET01547 | DBMET01547 | |
| 0.272 | 0.041 | 0.428 | Anesthetic general | 0.428 0.013 DBMET00839 0.428 0.013 DBMET00914 0.428 0.013 DBMET01547 | DBMET01547 | |
| 0.236 | 0.012 | 0.236 | Calcium channel (voltage-sensitive) blocker | 0.121 0.056 DBMET00839 0.121 0.056 DBMET00914 0.121 0.056 DBMET01547 | ||
| 0.305 | 0.087 | 0.339 | Calcium channel activator | 0.339 0.058 DBMET00839 0.339 0.058 DBMET00914 0.339 0.058 DBMET01547 | DBMET01547 | |
| 0.2 | 0.004 | 0.2 | Histamine agonist | 0.076 0.016 DBMET00839 0.076 0.016 DBMET00914 0.076 0.016 DBMET01547 | ||
| 0.2 | 0.008 | 0.2 | Neuronal nicotinic receptor antagonist | 0.134 0.014 DBMET00839 0.134 0.014 DBMET00914 0.134 0.014 DBMET01547 | ||
| 0.185 | 0.007 | 0.185 | Dopamine uptake inhibitor | 0.173 0.008 DBMET00839 0.173 0.008 DBMET00914 0.173 0.008 DBMET01547 | ||
| 0.319 | 0.146 | 0.474 | Cyclophilin D inhibitor | 0.474 0.058 DBMET00839 0.474 0.058 DBMET00914 0.474 0.058 DBMET01547 | DBMET01547 | |
| 0.188 | 0.023 | 0.188 | Antihistaminic | 0.084 0.072 DBMET00839 0.084 0.072 DBMET00914 0.084 0.072 DBMET01547 | ||
| 0.169 | 0.005 | 0.169 | Histamine H3 receptor agonist | 0.054 0.01 DBMET00839 0.054 0.01 DBMET00914 0.054 0.01 DBMET01547 | ||
| 0.21 | 0.047 | 0.21 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.167 | 0.005 | 0.167 | Gonadotropin-releasing hormone receptor antagonist | 0.063 0.013 DBMET00839 0.063 0.013 DBMET00914 0.063 0.013 DBMET01547 | ||
| 0.183 | 0.022 | 0.183 | Histamine antagonist | |||
| 0.182 | 0.022 | 0.182 | Sphingosine 1-phosphate receptor 5 antagonist | 0.132 0.096 DBMET00839 0.132 0.096 DBMET00914 0.132 0.096 DBMET01547 | ||
| 0.169 | 0.012 | 0.169 | Inducible nitric-oxide synthase inhibitor | 0.118 0.025 DBMET00839 0.118 0.025 DBMET00914 0.118 0.025 DBMET01547 | ||
| 0.166 | 0.013 | 0.166 | Acetylcholine nicotinic agonist | 0.079 0.058 DBMET00839 0.079 0.058 DBMET00914 0.079 0.058 DBMET01547 | ||
| 0.182 | 0.031 | 0.182 | Nav1.3 sodium channel blocker | 0.1 0.098 DBMET00839 0.1 0.098 DBMET00914 0.1 0.098 DBMET01547 | ||
| 0.18 | 0.03 | 0.18 | Neuropeptide Y1 antagonist | 0.128 0.104 DBMET00839 0.128 0.104 DBMET00914 0.128 0.104 DBMET01547 | ||
| 0.228 | 0.079 | 0.228 | Neuropeptide Y2 antagonist | |||
| 0.165 | 0.017 | 0.165 | Prolactin inhibitor | 0.136 0.029 DBMET00839 0.136 0.029 DBMET00914 0.136 0.029 DBMET01547 | ||
| 0.201 | 0.053 | 0.201 | Anticoagulant | 0.159 0.073 DBMET00839 0.159 0.073 DBMET00914 0.159 0.073 DBMET01547 | ||
| 0.162 | 0.023 | 0.162 | Acetylcholine agonist | 0.114 0.039 DBMET00839 0.114 0.039 DBMET00914 0.114 0.039 DBMET01547 | ||
| 0.193 | 0.057 | 0.193 | Src kinase inhibitor | |||
| 0.178 | 0.043 | 0.178 | Nav1.2 sodium channel blocker | 0.114 0.091 DBMET00839 0.114 0.091 DBMET00914 0.114 0.091 DBMET01547 | ||
| 0.138 | 0.004 | 0.138 | Nicotinic alpha3beta2 receptor antagonist | 0.137 0.004 DBMET00839 0.137 0.004 DBMET00914 0.137 0.004 DBMET01547 | ||
| 0.138 | 0.008 | 0.138 | Calcium channel T-type blocker | 0.059 0.039 DBMET00839 0.059 0.039 DBMET00914 0.059 0.039 DBMET01547 | ||
| 0.152 | 0.022 | 0.152 | Nitric-oxide synthase inhibitor | 0.098 0.063 DBMET00839 0.098 0.063 DBMET00914 0.098 0.063 DBMET01547 | ||
| 0.249 | 0.119 | 0.386 | Interleukin 2 agonist | 0.386 0.032 DBMET00839 0.386 0.032 DBMET00914 0.386 0.032 DBMET01547 | DBMET01547 | |
| 0.142 | 0.012 | 0.142 | Acetylcholine M2 receptor antagonist | 0.111 0.018 DBMET00839 0.111 0.018 DBMET00914 0.111 0.018 DBMET01547 | ||
| 0.252 | 0.125 | 0.311 | Antithrombotic | 0.311 0.081 DBMET00839 0.311 0.081 DBMET00914 0.311 0.081 DBMET01547 | DBMET01547 | |
| 0.241 | 0.115 | 0.241 | Ca(v)3.3 blocker | |||
| 0.165 | 0.041 | 0.2 | Adenylate cyclase stimulant | 0.2 0.014 DBMET00839 0.2 0.014 DBMET00914 0.2 0.014 DBMET01547 | DBMET01547 | |
| 0.132 | 0.007 | 0.132 | Dopamine transporter inhibitor | 0.101 0.012 DBMET00839 0.101 0.012 DBMET00914 0.101 0.012 DBMET01547 | ||
| 0.229 | 0.106 | 0.229 | Gastrin inhibitor | 0.21 0.134 DBMET00839 0.21 0.134 DBMET00914 0.21 0.134 DBMET01547 | ||
| 0.129 | 0.006 | 0.129 | Melanocortin 5 antagonist | 0.025 0.019 DBMET00839 0.025 0.019 DBMET00914 0.025 0.019 DBMET01547 | ||
| 0.12 | 0.002 | 0.12 | Phenylethanolamine N methyltransferase inhibitor | 0.09 0.003 DBMET00839 0.09 0.003 DBMET00914 0.09 0.003 DBMET01547 | ||
| 0.256 | 0.143 | 0.382 | Toll-Like receptor 7 agonist | 0.382 0.067 DBMET00839 0.382 0.067 DBMET00914 0.382 0.067 DBMET01547 | DBMET01547 | |
| 0.214 | 0.102 | 0.214 | Superoxide dismutase inhibitor | 0.198 0.12 DBMET00839 0.198 0.12 DBMET00914 0.198 0.12 DBMET01547 | ||
| 0.255 | 0.144 | 0.38 | Toll-Like receptor agonist | 0.38 0.069 DBMET00839 0.38 0.069 DBMET00914 0.38 0.069 DBMET01547 | DBMET01547 | |
| 0.17 | 0.062 | 0.17 | Neurotensin receptor agonist | |||
| 0.127 | 0.019 | 0.127 | 5 Hydroxytryptamine uptake inhibitor | 0.056 0.05 DBMET00839 0.056 0.05 DBMET00914 0.056 0.05 DBMET01547 | ||
| 0.159 | 0.052 | 0.197 | Neurotrophic factor | 0.197 0.029 DBMET00839 0.197 0.029 DBMET00914 0.197 0.029 DBMET01547 | DBMET01547 | |
| 0.116 | 0.01 | 0.116 | Nicotinic receptor alpha7 subunit antagonist | 0.072 0.02 DBMET00839 0.072 0.02 DBMET00914 0.072 0.02 DBMET01547 | ||
| 0.172 | 0.066 | 0.206 | Thrombolytic | 0.206 0.049 DBMET00839 0.206 0.049 DBMET00914 0.206 0.049 DBMET01547 | DBMET01547 | |
| 0.112 | 0.006 | 0.112 | Nicotinic receptor alpha4 subunit antagonist | 0.069 0.017 DBMET00839 0.069 0.017 DBMET00914 0.069 0.017 DBMET01547 | ||
| 0.147 | 0.044 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.119 | 0.018 | 0.119 | Thrombin inhibitor | 0.084 0.038 DBMET00839 0.084 0.038 DBMET00914 0.084 0.038 DBMET01547 | ||
| 0.111 | 0.01 | 0.111 | Histamine H3 receptor antagonist | |||
| 0.105 | 0.005 | 0.105 | Histamine H4 receptor antagonist | 0.05 0.031 DBMET00839 0.05 0.031 DBMET00914 0.05 0.031 DBMET01547 | ||
| 0.125 | 0.028 | 0.125 | Alpha 2a adrenoreceptor antagonist | |||
| 0.102 | 0.006 | 0.201 | Alpha-mannosidase inhibitor | 0.201 0.003 DBMET00839 0.201 0.003 DBMET00914 0.201 0.003 DBMET01547 | DBMET01547 | |
| 0.129 | 0.034 | 0.129 | Alpha 2 adrenoreceptor antagonist | 0.083 0.062 DBMET00839 0.083 0.062 DBMET00914 0.083 0.062 DBMET01547 | ||
| 0.129 | 0.035 | 0.129 | Acetylcholine release stimulant | |||
| 0.1 | 0.008 | 0.156 | Sphingosine kinase inhibitor | 0.156 0.004 DBMET00839 0.156 0.004 DBMET00914 0.156 0.004 DBMET01547 | DBMET01547 | |
| 0.107 | 0.015 | 0.107 | CC chemokine 5 receptor agonist | 0.081 0.06 DBMET00839 0.081 0.06 DBMET00914 0.081 0.06 DBMET01547 | ||
| 0.148 | 0.056 | 0.2 | Alpha-N-acetylglucosaminidase inhibitor | 0.2 0.034 DBMET00839 0.2 0.034 DBMET00914 0.2 0.034 DBMET01547 | DBMET01547 | |
| 0.132 | 0.042 | 0.132 | GABA C receptor antagonist | |||
| 0.122 | 0.034 | 0.122 | Acetylcholine M3 receptor agonist | 0.121 0.034 DBMET00839 0.121 0.034 DBMET00914 0.121 0.034 DBMET01547 | ||
| 0.095 | 0.007 | 0.095 | Prolyl endopeptidase inhibitor | 0.07 0.015 DBMET00839 0.07 0.015 DBMET00914 0.07 0.015 DBMET01547 | ||
| 0.115 | 0.028 | 0.115 | Alpha 2d adrenoreceptor antagonist | 0.091 0.067 DBMET00839 0.091 0.067 DBMET00914 0.091 0.067 DBMET01547 | ||
| 0.097 | 0.01 | 0.097 | Nicotinic receptor alpha3 subunit antagonist | 0.06 0.019 DBMET00839 0.06 0.019 DBMET00914 0.06 0.019 DBMET01547 | ||
| 0.135 | 0.048 | 0.135 | Calcium channel N-type blocker | |||
| 0.112 | 0.026 | 0.112 | Analgesic, opioid | 0.095 0.034 DBMET00839 0.095 0.034 DBMET00914 0.095 0.034 DBMET01547 | ||
| 0.106 | 0.023 | 0.106 | CXC chemokine 4 receptor antagonist | |||
| 0.094 | 0.012 | 0.094 | Melanocortin antagonist | 0.052 0.028 DBMET00839 0.052 0.028 DBMET00914 0.052 0.028 DBMET01547 | ||
| 0.2 | 0.121 | 0.28 | Interleukin agonist | 0.28 0.059 DBMET00839 0.28 0.059 DBMET00914 0.28 0.059 DBMET01547 | DBMET01547 | |
| 0.095 | 0.016 | 0.095 | Alpha 2 adrenoreceptor agonist | 0.064 0.038 DBMET00839 0.064 0.038 DBMET00914 0.064 0.038 DBMET01547 | ||
| 0.085 | 0.008 | 0.169 | Mannosidase inhibitor | 0.169 0.004 DBMET00839 0.169 0.004 DBMET00914 0.169 0.004 DBMET01547 | DBMET01547 | |
| 0.095 | 0.018 | 0.112 | MAP kinase kinase 7 inhibitor | 0.112 0.006 DBMET00839 0.112 0.006 DBMET00914 0.112 0.006 DBMET01547 | DBMET01547 | |
| 0.255 | 0.179 | 0.255 | Analgesic | 0.244 0.188 DBMET00839 0.244 0.188 DBMET00914 0.244 0.188 DBMET01547 | ||
| 0.199 | 0.125 | 0.269 | DNA synthesis inhibitor | 0.269 0.056 DBMET00839 0.269 0.056 DBMET00914 0.269 0.056 DBMET01547 | DBMET01547 | |
| 0.111 | 0.037 | 0.111 | Epidermal growth factor antagonist | |||
| 0.102 | 0.033 | 0.102 | Opioid kappa receptor antagonist | 0.096 0.039 DBMET00839 0.096 0.039 DBMET00914 0.096 0.039 DBMET01547 | ||
| 0.11 | 0.041 | 0.11 | Opioid antagonist | 0.096 0.051 DBMET00839 0.096 0.051 DBMET00914 0.096 0.051 DBMET01547 | ||
| 0.073 | 0.005 | 0.133 | Sphingosine kinase 1 inhibitor | 0.133 0.003 DBMET00839 0.133 0.003 DBMET00914 0.133 0.003 DBMET01547 | DBMET01547 | |
| 0.08 | 0.014 | 0.08 | Dipeptidyl peptidase inhibitor | |||
| 0.131 | 0.065 | 0.131 | Vanilloid 1 agonist | 0.13 0.065 DBMET00839 0.13 0.065 DBMET00914 0.13 0.065 DBMET01547 | ||
| 0.086 | 0.022 | 0.086 | Plasminogen activator inhibitor | 0.058 0.041 DBMET00839 0.058 0.041 DBMET00914 0.058 0.041 DBMET01547 | ||
| 0.086 | 0.022 | 0.086 | 5 Hydroxytryptamine 2A agonist | |||
| 0.084 | 0.021 | 0.084 | Acetylcholine muscarinic agonist | 0.069 0.028 DBMET00839 0.069 0.028 DBMET00914 0.069 0.028 DBMET01547 | ||
| 0.097 | 0.034 | 0.097 | 5 Hydroxytryptamine agonist | |||
| 0.069 | 0.006 | 0.069 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.086 | 0.024 | 0.086 | Trypsin inhibitor | 0.065 0.039 DBMET00839 0.065 0.039 DBMET00914 0.065 0.039 DBMET01547 | ||
| 0.068 | 0.006 | 0.068 | 5 Hydroxytryptamine 1D agonist | |||
| 0.078 | 0.018 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.046 DBMET00839 0.055 0.046 DBMET00914 0.055 0.046 DBMET01547 | ||
| 0.073 | 0.013 | 0.073 | 5 Hydroxytryptamine 2C agonist | 0.041 0.036 DBMET00839 0.041 0.036 DBMET00914 0.041 0.036 DBMET01547 | ||
| 0.288 | 0.229 | 0.288 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.114 | 0.056 | 0.114 | Aminopeptidase B inhibitor | |||
| 0.081 | 0.023 | 0.136 | Androgen agonist | 0.136 0.008 DBMET00839 0.136 0.008 DBMET00914 0.136 0.008 DBMET01547 | DBMET01547 | |
| 0.062 | 0.004 | 0.062 | Nicotinic alpha4beta2 receptor agonist | 0.028 0.021 DBMET00839 0.028 0.021 DBMET00914 0.028 0.021 DBMET01547 | ||
| 0.092 | 0.036 | 0.092 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.062 | 0.006 | 0.062 | Kainate receptor agonist | 0.06 0.007 DBMET00839 0.06 0.007 DBMET00914 0.06 0.007 DBMET01547 | ||
| 0.08 | 0.024 | 0.08 | Glutamate (mGluR6) antagonist | 0.077 0.028 DBMET00839 0.077 0.028 DBMET00914 0.077 0.028 DBMET01547 | ||
| 0.1 | 0.046 | 0.1 | Histamine N-methyltransferase inhibitor | |||
| 0.081 | 0.028 | 0.081 | NMDA receptor agonist | |||
| 0.063 | 0.012 | 0.063 | Dipeptidyl peptidase IV inhibitor | |||
| 0.087 | 0.036 | 0.087 | Aminopeptidase I inhibitor | 0.077 0.045 DBMET00839 0.077 0.045 DBMET00914 0.077 0.045 DBMET01547 | ||
| 0.093 | 0.043 | 0.093 | Adrenaline agonist | 0.093 0.042 DBMET00839 0.093 0.042 DBMET00914 0.093 0.042 DBMET01547 | ||
| 0.054 | 0.005 | 0.054 | Nicotinic alpha3beta4 receptor agonist | 0.034 0.016 DBMET00839 0.034 0.016 DBMET00914 0.034 0.016 DBMET01547 | ||
| 0.069 | 0.019 | 0.069 | Acetylcholine M1 receptor agonist | 0.049 0.026 DBMET00839 0.049 0.026 DBMET00914 0.049 0.026 DBMET01547 | ||
| 0.055 | 0.006 | 0.055 | Carnitine palmitoyltransferase inhibitor | 0.036 0.02 DBMET00839 0.036 0.02 DBMET00914 0.036 0.02 DBMET01547 | ||
| 0.084 | 0.034 | 0.084 | Vanilloid 4 agonist | 0.072 0.058 DBMET00839 0.072 0.058 DBMET00914 0.072 0.058 DBMET01547 | ||
| 0.055 | 0.005 | 0.055 | Carnitine palmitoyltransferase 1 inhibitor | 0.037 0.019 DBMET00839 0.037 0.019 DBMET00914 0.037 0.019 DBMET01547 | ||
| 0.052 | 0.004 | 0.052 | Nicotinic alpha4 receptor agonist | |||
| 0.11 | 0.061 | 0.11 | Falcipain 3 inhibitor | |||
| 0.071 | 0.022 | 0.071 | Prolactin release inhibitor | 0.066 0.032 DBMET00839 0.066 0.032 DBMET00914 0.066 0.032 DBMET01547 | ||
| 0.056 | 0.008 | 0.056 | Dipeptidyl peptidase II inhibitor | 0.035 0.019 DBMET00839 0.035 0.019 DBMET00914 0.035 0.019 DBMET01547 | ||
| 0.059 | 0.011 | 0.06 | Arginase inhibitor | 0.06 0.01 DBMET00839 0.06 0.01 DBMET00914 0.06 0.01 DBMET01547 | DBMET01547 | |
| 0.065 | 0.017 | 0.065 | Melanocortin 4 antagonist | |||
| 0.051 | 0.005 | 0.051 | Tryptophan 5 hydroxylase inhibitor | 0.048 0.006 DBMET00839 0.048 0.006 DBMET00914 0.048 0.006 DBMET01547 | ||
| 0.072 | 0.026 | 0.072 | Nicotinic neuronal receptor agonist | |||
| 0.068 | 0.023 | 0.099 | Sphingosine kinase 2 inhibitor | 0.099 0.008 DBMET00839 0.099 0.008 DBMET00914 0.099 0.008 DBMET01547 | DBMET01547 | |
| 0.091 | 0.046 | 0.091 | Neuropeptide Y antagonist | |||
| 0.096 | 0.051 | 0.096 | Ca(v)2.2 blocker | |||
| 0.061 | 0.016 | 0.061 | Oxytocin agonist | 0.052 0.023 DBMET00839 0.052 0.023 DBMET00914 0.052 0.023 DBMET01547 | ||
| 0.082 | 0.039 | 0.082 | Opioid mu receptor antagonist | 0.068 0.048 DBMET00839 0.068 0.048 DBMET00914 0.068 0.048 DBMET01547 | ||
| 0.071 | 0.029 | 0.071 | Cathepsin E inhibitor | 0.059 0.041 DBMET00839 0.059 0.041 DBMET00914 0.059 0.041 DBMET01547 | ||
| 0.053 | 0.011 | 0.053 | 5 Hydroxytryptamine 2B agonist | |||
| 0.112 | 0.071 | 0.148 | Microtubule formation inhibitor | 0.148 0.038 DBMET00839 0.148 0.038 DBMET00914 0.148 0.038 DBMET01547 | DBMET01547 | |
| 0.054 | 0.015 | 0.054 | Dopamine D5 agonist | 0.038 0.031 DBMET00839 0.038 0.031 DBMET00914 0.038 0.031 DBMET01547 | ||
| 0.058 | 0.018 | 0.058 | CC chemokine 4 receptor antagonist | |||
| 0.107 | 0.068 | 0.107 | 5 Hydroxytryptamine 3A agonist | |||
| 0.06 | 0.021 | 0.06 | HCV NS3/NS4A protease inhibitor | 0.053 0.029 DBMET00839 0.053 0.029 DBMET00914 0.053 0.029 DBMET01547 | ||
| 0.042 | 0.005 | 0.042 | Glutamate (mGluR1) agonist | |||
| 0.051 | 0.014 | 0.051 | GABA uptake inhibitor | |||
| 0.087 | 0.051 | 0.087 | Histamine H2 receptor antagonist | |||
| 0.099 | 0.063 | 0.099 | GABA C receptor rho-1 antagonist | |||
| 0.051 | 0.015 | 0.051 | AMPA 4 receptor antagonist | |||
| 0.046 | 0.011 | 0.046 | Glutamate (mGluR8) antagonist | 0.041 0.015 DBMET00839 0.041 0.015 DBMET00914 0.041 0.015 DBMET01547 | ||
| 0.061 | 0.026 | 0.061 | 5 Hydroxytryptamine 2 agonist | |||
| 0.04 | 0.005 | 0.04 | Imidazoline I1 receptor antagonist | |||
| 0.05 | 0.016 | 0.05 | Membrane dipeptidase inhibitor | 0.036 0.033 DBMET00839 0.036 0.033 DBMET00914 0.036 0.033 DBMET01547 | ||
| 0.082 | 0.048 | 0.113 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 DBMET00839 0.113 0.021 DBMET00914 0.113 0.021 DBMET01547 | DBMET01547 | |
| 0.088 | 0.054 | 0.088 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.051 | 0.018 | 0.051 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.077 | 0.043 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.053 | 0.019 | 0.053 | Histamine H2 receptor agonist | |||
| 0.049 | 0.017 | 0.049 | Nicotinic receptor beta4 subunit antagonist | 0.037 0.026 DBMET00839 0.037 0.026 DBMET00914 0.037 0.026 DBMET01547 | ||
| 0.129 | 0.098 | 0.13 | Hemostatic | 0.13 0.096 DBMET00839 0.13 0.096 DBMET00914 0.13 0.096 DBMET01547 | DBMET01547 | |
| 0.058 | 0.028 | 0.058 | CC chemokine 5 receptor antagonist | |||
| 0.051 | 0.021 | 0.051 | Geranyltranstransferase inhibitor | 0.042 0.033 DBMET00839 0.042 0.033 DBMET00914 0.042 0.033 DBMET01547 | ||
| 0.095 | 0.065 | 0.095 | Electrolyte absorption antagonist | |||
| 0.097 | 0.067 | 0.097 | Glutamate (mGluR7) agonist | 0.093 0.076 DBMET00839 0.093 0.076 DBMET00914 0.093 0.076 DBMET01547 | ||
| 0.042 | 0.013 | 0.042 | Peptide deformylase inhibitor | |||
| 0.035 | 0.007 | 0.035 | Glutamate (mGluR1a) agonist | |||
| 0.064 | 0.036 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.027 DBMET00839 0.066 0.027 DBMET00914 0.066 0.027 DBMET01547 | DBMET01547 | |
| 0.064 | 0.037 | 0.064 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.065 | 0.038 | 0.065 | NMDA 2C receptor antagonist | |||
| 0.037 | 0.011 | 0.037 | Lysine carboxypeptidase inhibitor | 0.024 0.022 DBMET00839 0.024 0.022 DBMET00914 0.024 0.022 DBMET01547 | ||
| 0.04 | 0.015 | 0.04 | ADAM10 endopeptidase inhibitor | 0.035 0.021 DBMET00839 0.035 0.021 DBMET00914 0.035 0.021 DBMET01547 | ||
| 0.034 | 0.008 | 0.034 | Motilin receptor agonist | 0.029 0.01 DBMET00839 0.029 0.01 DBMET00914 0.029 0.01 DBMET01547 | ||
| 0.055 | 0.031 | 0.055 | Sigma receptor antagonist | |||
| 0.098 | 0.074 | 0.098 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.084 | 0.06 | 0.084 | NMDA receptor antagonist | |||
| 0.042 | 0.02 | 0.042 | Somatostatin 4 agonist | |||
| 0.262 | 0.239 | 0.337 | Caspase 9 stimulant | 0.337 0.156 DBMET00839 0.337 0.156 DBMET00914 0.337 0.156 DBMET01547 | DBMET01547 | |
| 0.057 | 0.035 | 0.089 | Glucosylceramidase inhibitor | 0.089 0.012 DBMET00839 0.089 0.012 DBMET00914 0.089 0.012 DBMET01547 | DBMET01547 | |
| 0.11 | 0.089 | 0.11 | Cathepsin H inhibitor | |||
| 0.029 | 0.008 | 0.029 | 5 Hydroxytryptamine 4 agonist | 0.025 0.014 DBMET00839 0.025 0.014 DBMET00914 0.025 0.014 DBMET01547 | ||
| 0.036 | 0.015 | 0.036 | Dipeptidyl peptidase I inhibitor | |||
| 0.107 | 0.087 | 0.107 | Transcription factor STAT6 inhibitor | |||
| 0.092 | 0.072 | 0.092 | Chemokine receptor antagonist | |||
| 0.04 | 0.021 | 0.059 | Glucose-6-phosphate dehydrogenase inhibitor | 0.059 0.007 DBMET00839 0.059 0.007 DBMET00914 0.059 0.007 DBMET01547 | DBMET01547 | |
| 0.107 | 0.088 | 0.107 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.047 | 0.028 | 0.047 | Dihydroorotase inhibitor | |||
| 0.031 | 0.013 | 0.031 | Motilin receptor antagonist | 0.026 0.023 DBMET00839 0.026 0.023 DBMET00914 0.026 0.023 DBMET01547 | ||
| 0.066 | 0.049 | 0.066 | Alpha adrenoreceptor agonist | |||
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR4) antagonist | |||
| 0.048 | 0.032 | 0.048 | Aldosterone antagonist | 0.048 0.032 DBMET00839 0.048 0.032 DBMET00914 0.048 0.032 DBMET01547 | ||
| 0.025 | 0.008 | 0.025 | Integrin alphaVbeta1 antagonist | 0.019 0.013 DBMET00839 0.019 0.013 DBMET00914 0.019 0.013 DBMET01547 | ||
| 0.044 | 0.029 | 0.044 | Histamine H1 receptor agonist | |||
| 0.031 | 0.016 | 0.031 | 5 Hydroxytryptamine 6 agonist | |||
| 0.037 | 0.023 | 0.037 | Growth hormone secretagogue receptor agonist | |||
| 0.075 | 0.061 | 0.075 | Viral attachment inhibitor | |||
| 0.06 | 0.048 | 0.06 | Histone deacetylase SIRT3 inhibitor | |||
| 0.033 | 0.021 | 0.033 | Glutamate (mGluR3) agonist | 0.031 0.026 DBMET00839 0.031 0.026 DBMET00914 0.031 0.026 DBMET01547 | ||
| 0.034 | 0.022 | 0.034 | Trypsin I inhibitor | |||
| 0.022 | 0.011 | 0.022 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.08 | 0.069 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.13 | 0.119 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.135 0.096 DBMET00839 0.135 0.096 DBMET00914 0.135 0.096 DBMET01547 | DBMET01547 | |
| 0.081 | 0.071 | 0.081 | Alpha adrenoreceptor antagonist | |||
| 0.108 | 0.098 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.053 | 0.044 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.019 | 0.009 | 0.019 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.014 DBMET00839 0.017 0.014 DBMET00914 0.017 0.014 DBMET01547 | ||
| 0.022 | 0.013 | 0.022 | Integrin beta5 antagonist | |||
| 0.04 | 0.031 | 0.04 | CC chemokine 3 receptor antagonist | |||
| 0.017 | 0.009 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DBMET00839 0.014 0.013 DBMET00914 0.014 0.013 DBMET01547 | ||
| 0.02 | 0.012 | 0.02 | Melatonin 3 antagonist | |||
| 0.041 | 0.033 | 0.041 | NMDA receptor subunit 3B antagonist | |||
| 0.027 | 0.019 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.037 | 0.03 | 0.037 | Substance P antagonist | |||
| 0.085 | 0.079 | 0.085 | Check point kinase 2 inhibitor | |||
| 0.07 | 0.064 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.028 | 0.022 | 0.028 | AMPA 3 receptor antagonist | |||
| 0.04 | 0.035 | 0.041 | GABA B receptor antagonist | 0.041 0.034 DBMET00839 0.041 0.034 DBMET00914 0.041 0.034 DBMET01547 | DBMET01547 | |
| 0.018 | 0.013 | 0.018 | Complement factor D inhibitor | |||
| 0.034 | 0.03 | 0.034 | Melanocortin 1 antagonist | |||
| 0.022 | 0.018 | 0.022 | Aminopeptidase P inhibitor | |||
| 0.034 | 0.031 | 0.034 | NMDA receptor subunit 3A antagonist | |||
| 0.025 | 0.022 | 0.025 | Somatostatin 2 antagonist | |||
| 0.043 | 0.04 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET00839 0.044 0.036 DBMET00914 0.044 0.036 DBMET01547 | DBMET01547 | |
| 0.166 | 0.163 | 0.166 | Nitric-oxide synthase stimulant | |||
| 0.046 | 0.044 | 0.046 | Opioid agonist | |||
| 0.018 | 0.016 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.03 | 0.029 | 0.03 | Carboxypeptidase B inhibitor | |||
| 0.058 | 0.057 | 0.058 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.052 | 0.051 | 0.052 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.015 | 0.017 | 0.019 | Cyclin T1 inhibitor | 0.019 0.012 DBMET00839 0.019 0.012 DBMET00914 0.019 0.012 DBMET01547 | DBMET01547 | |
| 0.07 | 0.074 | 0.093 | Glycine receptor antagonist | 0.093 0.04 DBMET00839 0.093 0.04 DBMET00914 0.093 0.04 DBMET01547 | DBMET01547 | |
| 0.031 | 0.038 | 0.043 | Glutamate (mGluR3) antagonist | 0.043 0.018 DBMET00839 0.043 0.018 DBMET00914 0.043 0.018 DBMET01547 | DBMET01547 | |
| 0.114 | 0.121 | 0.157 | Insulin secretagoues | 0.157 0.067 DBMET00839 0.157 0.067 DBMET00914 0.157 0.067 DBMET01547 | DBMET01547 | |
| 0.029 | 0.042 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.046 0.009 DBMET00839 0.046 0.009 DBMET00914 0.046 0.009 DBMET01547 | DBMET01547 | |
| 0.011 | 0.026 | 0.016 | Thromboxane A2 agonist | 0.016 0.01 DBMET00839 0.016 0.01 DBMET00914 0.016 0.01 DBMET01547 | DBMET01547 | |
| 0.145 | 0.159 | 0.262 | Immunostimulant | 0.262 0.091 DBMET00839 0.262 0.091 DBMET00914 0.262 0.091 DBMET01547 | DBMET01547 | |
| 0.032 | 0.048 | 0.041 | Opioid kappa receptor agonist | 0.041 0.033 DBMET00839 0.041 0.033 DBMET00914 0.041 0.033 DBMET01547 | DBMET01547 | |
| 0.061 | 0.078 | 0.092 | Glycine receptor agonist | 0.092 0.026 DBMET00839 0.092 0.026 DBMET00914 0.092 0.026 DBMET01547 | DBMET01547 | |
| 0.057 | 0.075 | 0.065 | Protein kinase C beta inhibitor | 0.065 0.059 DBMET00839 0.065 0.059 DBMET00914 0.065 0.059 DBMET01547 | DBMET01547 | |
| 0.119 | 0.137 | 0.166 | Interferon gamma antagonist | 0.166 0.061 DBMET00839 0.166 0.061 DBMET00914 0.166 0.061 DBMET01547 | DBMET01547 | |
| 0.094 | 0.113 | 0.105 | Cyclooxygenase 3 inhibitor | 0.105 0.097 DBMET00839 0.105 0.097 DBMET00914 0.105 0.097 DBMET01547 | DBMET01547 | |
| 0.037 | 0.058 | 0.066 | Protein 50S ribosomal subunit inhibitor | 0.066 0.027 DBMET00839 0.066 0.027 DBMET00914 0.066 0.027 DBMET01547 | DBMET01547 | |
| 0.079 | 0.101 | 0.122 | Anabolic | 0.122 0.037 DBMET00839 0.122 0.037 DBMET00914 0.122 0.037 DBMET01547 | DBMET01547 | |
| 0.1 | 0.122 | 0.164 | Protein kinase stimulant | 0.164 0.059 DBMET00839 0.164 0.059 DBMET00914 0.164 0.059 DBMET01547 | DBMET01547 | |
| 0.015 | 0.046 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 DBMET00839 0.02 0.016 DBMET00914 0.02 0.016 DBMET01547 | DBMET01547 | |
| 0.074 | 0.107 | 0.128 | Expectorant | 0.128 0.046 DBMET00839 0.128 0.046 DBMET00914 0.128 0.046 DBMET01547 | DBMET01547 | |
| 0.114 | 0.149 | 0.138 | Melanin inhibitor | 0.138 0.1 DBMET00839 0.138 0.1 DBMET00914 0.138 0.1 DBMET01547 | DBMET01547 | |
| 0.021 | 0.057 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DBMET00839 0.03 0.013 DBMET00914 0.03 0.013 DBMET01547 | DBMET01547 | |
| 0.02 | 0.062 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET00839 0.025 0.024 DBMET00914 0.025 0.024 DBMET01547 | DBMET01547 | |
| 0.122 | 0.178 | 0.176 | Phospholipase C inhibitor | 0.176 0.065 DBMET00839 0.176 0.065 DBMET00914 0.176 0.065 DBMET01547 | DBMET01547 | |
| 0.101 | 0.157 | 0.139 | Arachidonic acid antagonist | 0.139 0.102 DBMET00839 0.139 0.102 DBMET00914 0.139 0.102 DBMET01547 | DBMET01547 | |
| 0.073 | 0.131 | 0.112 | Mucolytic | 0.112 0.062 DBMET00839 0.112 0.062 DBMET00914 0.112 0.062 DBMET01547 | DBMET01547 | |
| 0.073 | 0.135 | 0.165 | Amylase inhibitor | 0.165 0.057 DBMET00839 0.165 0.057 DBMET00914 0.165 0.057 DBMET01547 | DBMET01547 | |
| 0.077 | 0.14 | 0.127 | Bone formation stimulant | 0.127 0.079 DBMET00839 0.127 0.079 DBMET00914 0.127 0.079 DBMET01547 | DBMET01547 | |
| 0.065 | 0.133 | 0.104 | Lanosterol 14 alpha demethylase inhibitor | 0.104 0.049 DBMET00839 0.104 0.049 DBMET00914 0.104 0.049 DBMET01547 | DBMET01547 | |
| 0.069 | 0.139 | 0.128 | Cholesterol synthesis inhibitor | 0.128 0.058 DBMET00839 0.128 0.058 DBMET00914 0.128 0.058 DBMET01547 | DBMET01547 | |
| 0.013 | 0.084 | 0.028 | Prostaglandin D2 agonist | 0.028 0.025 DBMET00839 0.028 0.025 DBMET00914 0.028 0.025 DBMET01547 | DBMET01547 | |
| 0.022 | 0.097 | 0.034 | Tubulin agonist | 0.034 0.024 DBMET00839 0.034 0.024 DBMET00914 0.034 0.024 DBMET01547 | DBMET01547 | |
| 0.063 | 0.148 | 0.099 | Bile acid receptor antagonist | 0.099 0.052 DBMET00839 0.099 0.052 DBMET00914 0.099 0.052 DBMET01547 | DBMET01547 | |
| 0.044 | 0.135 | 0.085 | Androgen antagonist | 0.085 0.06 DBMET00839 0.085 0.06 DBMET00914 0.085 0.06 DBMET01547 | DBMET01547 | |
| 0.143 | 0.235 | 0.287 | Cholesterol antagonist | 0.287 0.1 DBMET00839 0.287 0.1 DBMET00914 0.287 0.1 DBMET01547 | DBMET01547 | |
| 0.112 | 0.209 | 0.16 | Neurotrophic factor enhancer | 0.16 0.124 DBMET00839 0.16 0.124 DBMET00914 0.16 0.124 DBMET01547 | DBMET01547 | |
| 0.059 | 0.167 | 0.121 | Adenylate cyclase inhibitor | 0.121 0.067 DBMET00839 0.121 0.067 DBMET00914 0.121 0.067 DBMET01547 | DBMET01547 | |
| 0.148 | 0.257 | 0.387 | Immunosuppressant | 0.387 0.069 DBMET00839 0.387 0.069 DBMET00914 0.387 0.069 DBMET01547 | DBMET01547 | |
| 0.106 | 0.22 | 0.156 | ATPase inhibitor | 0.156 0.091 DBMET00839 0.156 0.091 DBMET00914 0.156 0.091 DBMET01547 | DBMET01547 | |
| 0.07 | 0.206 | 0.231 | Angiogenesis stimulant | 0.231 0.079 DBMET00839 0.231 0.079 DBMET00914 0.231 0.079 DBMET01547 | DBMET01547 | |
| 0.019 | 0.16 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.03 DBMET00839 0.033 0.03 DBMET00914 0.033 0.03 DBMET01547 | DBMET01547 | |
| 0.005 | 0.154 | 0.042 | RNA-directed RNA polymerase stimulant | 0.042 0.016 DBMET00839 0.042 0.016 DBMET00914 0.042 0.016 DBMET01547 | DBMET01547 | |
| 0.017 | 0.197 | 0.071 | Antineoplastic antibiotic | 0.071 0.064 DBMET00839 0.071 0.064 DBMET00914 0.071 0.064 DBMET01547 | DBMET01547 | |
| 0.138 | 0.319 | 0.251 | Antibacterial | 0.251 0.176 DBMET00839 0.251 0.176 DBMET00914 0.251 0.176 DBMET01547 | DBMET01547 | |
| 0.026 | 0.211 | 0.047 | Parathyroid hormone antagonist | 0.047 0.026 DBMET00839 0.047 0.026 DBMET00914 0.047 0.026 DBMET01547 | DBMET01547 | |
| 0.108 | 0.366 | 0.354 | Sodium/bile acid cotransporter inhibitor | 0.354 0.037 DBMET00839 0.354 0.037 DBMET00914 0.354 0.037 DBMET01547 | DBMET01547 | |
| 0.028 | 0.318 | 0.113 | Bronchodilator | 0.113 0.05 DBMET00839 0.113 0.05 DBMET00914 0.113 0.05 DBMET01547 | DBMET01547 | |
| 0.077 | 0.369 | 0.164 | Hypoglycemic | 0.164 0.156 DBMET00839 0.164 0.156 DBMET00914 0.164 0.156 DBMET01547 | DBMET01547 | |
| 0.058 | 0.362 | 0.172 | Hepatoprotectant | 0.172 0.087 DBMET00839 0.172 0.087 DBMET00914 0.172 0.087 DBMET01547 | DBMET01547 | |
| 0.075 | 0.392 | 0.137 | MAP kinase kinase 4 inhibitor | 0.137 0.093 DBMET00839 0.137 0.093 DBMET00914 0.137 0.093 DBMET01547 | DBMET01547 | |
| 0.03 | 0.469 | 0.178 | Hypolipemic | 0.178 0.111 DBMET00839 0.178 0.111 DBMET00914 0.178 0.111 DBMET01547 | DBMET01547 | |
| 0.057 | 0.542 | 0.146 | Lipocortins synthesis antagonist | 0.146 0.111 DBMET00839 0.146 0.111 DBMET00914 0.146 0.111 DBMET01547 | DBMET01547 | |
| 0.075 | 0.658 | 0.226 | Peptidyltransferase inhibitor | 0.226 0.07 DBMET00839 0.226 0.07 DBMET00914 0.226 0.07 DBMET01547 | DBMET01547 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |